# Medical Record Results for Member ID: 15163

## Member ID

15163

## Basic Info

```markdown
Member Information

Member ID: 15163
Age: 74
Gender: Female
```

## Diagnosis Summary

Diagnosis Summary:

Cardiovascular Conditions:
- Essential Primary Hypertension (I10) in [2017-05-26, 2017-08-07, 2017-08-13, 2017-08-15, 2017-11-17, 2017-11-29, 2018-05-10, 2018-06-20, 2018-07-17, 2019-08-19, 2019-08-26, 2019-09-11, 2019-09-17]
- HTN CKD W/STAGE 1-4 CKD/UNS CKD (I129) in [2017-07-21, 2017-08-13, 2017-08-14, 2017-09-30, 2017-10-05, 2017-10-31, 2017-11-30, 2017-12-31, 2018-01-19, 2018-01-25, 2018-01-31, 2018-02-27, 2018-02-28, 2018-03-02, 2018-03-27, 2018-03-31, 2018-04-30, 2018-06-30, 2018-07-31, 2018-08-07, 2018-09-04, 2018-09-18, 2018-10-04, 2018-11-08, 2018-12-03, 2018-12-19, 2019-01-07, 2019-01-14, 2019-02-18, 2019-02-19, 2019-03-19, 2019-05-14, 2019-07-16, 2019-07-30]
- Unspecified Atrial Fibrillation (I4891) in [2017-08-13, 2017-08-14]
- Hypertensive Urgency (I160) in [2017-08-15]
- Cerebral Atherosclerosis (I672) in [2019-08-26, 2019-09-10]
- Nonrheumatic Mitral Insufficiency (I340) in [2019-09-10]
- Cardiomegaly (I517) in [2019-09-17]

Respiratory Conditions:
- Acute Bronchitis Unspecified (J209) in [2017-07-07, 2017-07-21, 2018-05-10, 2019-04-17, 2019-06-18]
- Allergic Rhinitis Unspecified (J309) in [2017-11-17, 2018-12-19, 2019-07-30, 2019-08-19]
- Acute Sinusitis Unspecified (J0190) in [2017-11-17, 2019-08-19, 2019-09-11]
- COPD Unspecified (J449) in [2019-03-19]

Renal Conditions:
- CKD Stage 3 Moderate (N183) in [2017-07-21, 2017-08-07, 2017-09-30, 2017-10-05, 2017-10-09, 2017-10-31, 2017-11-30, 2017-12-31, 2018-01-25, 2018-01-31, 2018-02-27, 2018-02-28, 2018-03-02, 2018-03-27, 2018-03-31, 2018-04-30, 2018-06-30, 2018-07-31, 2018-09-04, 2018-10-04, 2018-11-08, 2018-12-03, 2019-02-18, 2019-02-19, 2019-04-17, 2019-06-18, 2019-07-16]
- Acute Kidney Failure Unspecified (N179) in [2017-08-13, 2017-08-14]

Endocrine and Metabolic Conditions:
- Type 2 DM Without Complications (E119) in [2017-05-26]
- Prediabetes (R7303) in [2017-07-21]
- Hyperlipidemia Unspecified (E785) in [2018-09-18, 2018-11-08, 2019-02-19, 2019-03-19, 2019-04-17]
- Pure Hypercholesterolemia Unspec (E7800) in [2018-12-19, 2019-07-16, 2019-07-30]
- Mixed Hyperlipidemia (E782) in [2019-08-26, 2019-09-10, 2019-09-17]

Musculoskeletal Conditions:
- Pain in Right Knee (M25561) in [2017-07-07, 2018-01-25, 2018-02-27, 2018-06-20, 2018-07-17, 2019-02-18, 2019-03-19, 2019-04-17, 2019-05-14, 2019-06-18]
- Unspecified Osteoarthritis Uns Site (M1990) in [2018-01-19, 2018-02-27, 2018-03-27, 2018-05-22, 2018-06-18, 2018-07-16, 2018-08-17, 2018-09-18, 2018-11-08, 2018-12-03, 2018-12-19, 2019-01-07, 2019-01-14, 2019-03-19, 2019-06-18, 2019-07-16, 2019-07-30, 2019-08-19]

Gastrointestinal Conditions:
- Constipation Unspecified (K5900) in [2017-11-17, 2017-11-29]
- Melena (K921) in [2017-10-05, 2017-10-09, 2017-11-17, 2017-11-29]
- Gastritis Uns Without Bleeding (K2970) in [2018-01-19]
- Functional Dyspepsia (K30) in [2018-01-19]
- Other Hemorrhoids (K648) in [2018-01-19]

Neurological Conditions:
- Unspecified Atrial Fibrillation (I4891) in [2017-08-13, 2017-08-14]
- Dizziness and Giddiness (R42) in [2019-02-18, 2019-07-16]
- Headache (R51) in [2018-01-19, 2019-07-30, 2019-08-19]

Psychiatric Conditions:
- Nicotine Depend Oth Tob Prod Uncomp (F17290) in [2017-07-07, 2017-07-21, 2017-08-07, 2017-09-30, 2017-10-31, 2017-11-17, 2017-11-30, 2017-12-31, 2018-01-19, 2018-01-25, 2018-01-31, 2018-02-28, 2018-03-02, 2018-03-31, 2018-04-30, 2018-05-10, 2018-05-22, 2018-06-20, 2018-06-30, 2018-07-17, 2018-07-31, 2018-08-17, 2018-09-18, 2018-11-08, 2018-12-03, 2019-01-07, 2019-01-14, 2019-02-19, 2019-03-19, 2019-04-17, 2019-05-14, 2019-06-18, 2019-07-16, 2019-07-30, 2019-08-19, 2019-09-11]
- Nicotine Depend Uns Uncomplicated (F17200) in [2017-08-15, 2017-10-05, 2017-11-29, 2018-02-27, 2018-12-19, 2019-01-07, 2019-03-19, 2019-07-16, 2019-07-30, 2019-08-19, 2019-09-11]
- Nicotine Depend Cigarettes Uncomp (F17210) in [2018-01-19, 2019-07-30, 2019-09-11]
- Opioid Use Uns Uncomplicated (F1190) in [2019-03-19]

Other Conditions:
- Anemia Unspecified (D649) in [2017-09-30, 2017-10-05, 2017-10-09, 2017-10-31, 2017-11-30, 2017-12-31, 2018-01-25, 2018-01-31, 2018-02-28, 2018-03-02, 2018-03-31, 2018-04-17, 2018-06-30, 2018-07-31, 2018-08-17, 2018-09-04, 2018-09-18, 2018-11-08, 2018-12-03, 2019-01-07, 2019-01-14, 2019-02-18, 2019-03-19, 2019-04-17, 2019-05-14, 2019-06-18, 2019-07-16, 2019-07-30, 2019-08-19, 2019-09-11]
- Insomnia Unspecified (G4700) in [2017-07-07, 2018-02-27, 2018-03-27, 2018-06-20, 2018-07-17]
- Dysphonia (R490) in [2017-07-07, 2017-07-21, 2018-03-27, 2018-04-17, 2018-07-17]
- Overweight (E663) in [2018-04-17, 2018-05-22, 2018-06-20]
- Body Mass Index BMI 24.0-24.9 Adult (Z6824) in [2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-03-27, 2018-05-10]
- Body Mass Index BMI 25.0-25.9 Adult (Z6825) in [2018-04-17, 2018-05-22]
- Body Mass Index BMI 26.0-26.9 Adult (Z6826) in [2018-06-20]
- Encounter Screen Malig Neoplasm Colon (Z1211) in [2018-01-09, 2018-01-19, 2019-07-16]
- Encounter Screen for Other Disorder (Z1389) in [2018-01-25]
- Encounter Screen for Osteoporosis (Z13820) in [2019-07-16]
- Encounter for Screening for DM (Z131) in [2018-12-19]
- Encounter for Immunization (Z23) in [2018-12-19]
- Acq Absence Utrus Rem Cerv Stump (Z90711) in [2018-12-19, 2019-07-16]
- Other Chronic Pain (G8929) in [2019-09-11]
- Chronic Pain Syndrome (G894) in [2019-03-19]
- Other Fecal Abnormalities (R195) in [2018-01-09, 2018-01-19]
- Abnormal Weight Loss (R634) in [2018-01-09, 2018-01-19]
- Early Satiety (R6881) in [2018-01-09, 2018-01-19]
- Other Spec Abnormal Findings Bld Chem (R7989) in [2017-10-05, 2017-10-09, 2017-11-20, 2017-11-29, 2018-01-25, 2018-03-27, 2018-06-18, 2019-04-17, 2019-07-16]
- Other Spec Sx Signs Invlv Circ Rs (R0989) in [2017-08-07, 2018-07-17]
- Bradycardia Unspecified (R001) in [2017-07-07, 2019-09-17]
- Nausea with Vomiting Unspecified (R112) in [2017-08-13, 2017-08-14, 2019-08-19]
- Vomiting Unspecified (R1110) in [2017-08-13]
- Dysarthria and Anarthria (R471) in [2019-08-19]
- Abnormal Electrocardiogram (R9431) in [2019-08-26, 2019-09-10]
- Other Non-Specific Abn Find Lng Field (R918) in [2018-05-22]
- Other Disorders of Lung (J984) in [2017-11-29]
- Acute Maxillary Sinusitis Uns (J0100) in [2019-01-07]
- Acute Nasopharyngitis Common Cold (J00) in [2019-04-17]
- Cough (R05) in [2019-05-14]
- Dizziness and Giddiness (R42) in [2019-02-18, 2019-07-16]
- Abnormal Weight Loss (R634) in [2018-01-09, 2018-01-19]
- Early Satiety (R6881) in [2018-01-09, 2018-01-19]
- Other Spec Abnormal Findings Bld Chem (R7989) in [2017-10-05, 2017-10-09, 2017-11-20, 2017-11-29, 2018-01-25, 2018-03-27, 2018-06-18, 2019-04-17, 2019-07-16]
- Other Spec Sx Signs Invlv Circ Rs (R0989) in [2017-08-07, 2018-07-17]
- Bradycardia Unspecified (R001) in [2017-07-07, 2019-09-17]
- Nausea with Vomiting Unspecified (R112) in [2017-08-13, 2017-08-14, 2019-08-19]
- Vomiting Unspecified (R1110) in [2017-08-13]
- Dysarthria and Anarthria (R471) in [2019-08-19]
- Abnormal Electrocardiogram (R9431) in [2019-08-26, 2019-09-10]
- Other Non-Specific Abn Find Lng Field (R918) in [2018-05-22]
- Other Disorders of Lung (J984) in [2017-11-29]
- Acute Maxillary Sinusitis Uns (J0100) in [2019-01-07]
- Acute Nasopharyngitis Common Cold (J00) in [2019-04-17]
- Cough (R05) in [2019-05-14]

## Procedure Summary

Procedure Summary:

Cardiovascular Procedures:
1. ELECTROCARDIOGRAM COMPLETE (93000) in [2017-05-26, 2017-11-17, 2019-07-16, 2019-08-26]
2. ELECTROCARDIOGRAM TRACING (93005) in [2017-08-13, 2017-08-14]
3. CARDIOVASCULAR STRESS TEST (93015) in [2019-09-10]
4. TTE W/DOPPLER COMPLETE (93306) in [2019-09-10]

Imaging Procedures:
1. CHEST X-RAY 2VW FRONTAL&LATL (71020) in [2017-08-13, 2017-08-14]
2. CT ABD & PELVIS W/O CONTRAST (74176) in [2017-08-13, 2017-08-14]
3. CT THORAX DX C+ (71260) in [2017-11-20]
4. CT ABD & PELV W/CONTRAST (74177) in [2017-11-20]

Laboratory Tests:
1. METABOLIC PANEL TOTAL CA (80048) in [2017-08-13, 2017-08-14]
2. HEPATIC FUNCTION PANEL (80076) in [2017-08-13, 2017-08-14]
3. URINALYSIS AUTO W/SCOPE (81001) in [2017-08-13, 2017-08-14]
4. URINALYSIS NONAUTO W/O SCOPE (81002) in [2019-02-18, 2019-07-16, 2019-08-19]
5. ASSAY OF LIPASE (83690) in [2017-08-13, 2017-08-14]
6. ASSAY OF TROPONIN QUANT (84484) in [2017-08-13, 2017-08-14]
7. COMPLETE CBC W/AUTO DIFF WBC (85025) in [2017-08-13, 2017-08-14]
8. INFLUENZA ASSAY W/OPTIC (87804) in [2019-04-17]
9. ASSAY TEST FOR BLOOD FECAL (82274) in [2019-07-16]

Office Visits:
1. OFFICE O/P EST LOW 20-29 MIN (99213) in [2017-05-26, 2017-07-07, 2017-08-15, 2018-04-17, 2018-08-17]
2. OFFICE O/P EST MOD 30-39 MIN (99214) in [2017-07-21, 2017-08-07, 2017-10-05, 2017-11-17, 2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-03-27, 2018-05-22, 2018-06-20, 2018-07-17, 2018-09-18, 2018-12-19, 2019-01-07, 2019-02-18, 2019-03-19, 2019-04-17, 2019-05-14, 2019-06-18, 2019-07-16, 2019-07-30, 2019-08-19, 2019-09-11, 2019-09-17]
3. OFFICE O/P NEW LOW 30-44 MIN (99203) in [2018-01-09]
4. OFFICE O/P NEW MOD 45-59 MIN (99204) in [2019-08-26]

Smoking and Tobacco Use Assessments:
1. SMOKER/EXPOSED 2ND HND SMOKE (1032F) in [2017-07-07, 2017-07-21, 2017-08-07, 2017-11-17, 2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-04-17, 2018-05-22, 2018-06-20, 2018-07-17]
2. CURRENT TOBACCO SMOKER (1034F) in [2017-07-07, 2017-07-21, 2017-08-07, 2017-11-17, 2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-04-17, 2018-06-20, 2018-07-17]
3. SMOKING & 2ND HAND ASSESSED (1031F) in [2017-08-07, 2017-08-15, 2017-10-05, 2018-02-27]
4. TOBACCO NONSMOKER NOR 2NDHND (1033F) in [2018-05-10]
5. TOBACCO NON-USER (1036F) in [2018-05-10, 2019-07-16]
6. SMOKELESS TOBACCO USER (1035F) in [2018-05-22]
7. TOBACCO USE ASSESSED (1000F) in [2019-07-16]

Behavioral and Nutritional Counseling:
1. BEHAV CHNG SMOKING 3-10 MIN (99406) in [2017-07-07, 2017-07-21, 2017-08-15, 2017-11-17, 2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-04-17, 2018-05-22, 2018-06-20, 2018-07-17]
2. MEDICAL NUTRITION INDIV IN (97802) in [2017-10-05, 2017-10-09, 2017-11-17, 2017-11-29, 2018-01-25, 2018-02-27, 2018-03-02, 2018-03-27, 2018-04-17, 2018-05-22, 2018-06-20]
3. FCE-FCE BEHAVRL CNSL OBESITY 15 MIN (G0447) in [2018-03-27, 2018-04-17, 2018-06-20]

Chronic Care Management:
1. CHRNC CARE MGMT STAFF 1ST 20 (99490) in [2017-09-30, 2017-10-31, 2017-11-30, 2017-12-31, 2018-01-31, 2018-02-28, 2018-03-31, 2018-04-30, 2018-06-30, 2018-07-31, 2018-08-07, 2018-09-04, 2018-10-04, 2018-11-08, 2018-12-03, 2019-01-14, 2019-02-19]

Emergency and Observation Services:
1. EMERGENCY DEPT VISIT (99285) in [2017-08-13, 2017-08-14]
2. HOSPITAL OBSERVATN SERVICE PER HOUR (G0378) in [2017-08-13, 2017-08-14]
3. INITIAL OBSERVATION CARE (99220) in [2017-08-14]

Other Procedures:
1. EGD BIOPSY SINGLE/MULTIPLE (43239) in [2018-01-19]
2. DIAGNOSTIC COLONOSCOPY (45378) in [2018-01-19]
3. H PYLORI (C-13) BREATH (83013) in [2018-01-19]
4. TISSUE EXAM BY PATHOLOGIST (88305) in [2018-01-19]
5. IMMUNOHISTO ANTB 1ST STAIN (88342) in [2018-01-19]
6. INJECTION MIDAZOLAM HCL PER 1 MG (J2250) in [2018-01-19]
7. INJECTION FENTANYL CITRATE 0.1 MG (J3010) in [2018-01-19]
8. INJECTION ONDANSETRON HCL PER 1 MG (J2405) in [2017-08-13, 2017-08-14]
9. THER/PROPH/DIAG INJ IV PUSH (96374) in [2017-08-13, 2017-08-14, 2017-11-20]
10. TX/PRO/DX INJ NEW DRUG ADDON (96375) in [2017-08-13, 2017-08-14]
11. TX/PRO/DX INJ SAME DRUG ADON (96376) in [2017-08-13, 2017-08-14]
12. LOCM 300-399 MG/ML I CONC PER ML (Q9967) in [2017-11-20]
13. ROUTINE VENIPUNCTURE (36415) in [2019-09-11]
14. SPECIMEN HANDLING OFFICE-LAB (99000) in [2019-03-19]

This summary includes all procedures and their associated dates as per the input data, ensuring no procedure or date is omitted.

## Medication Summary

Prescription Medication Summary:

Antibiotics:
- Amoxicillin (01200010) in [2017-05-24, 2017-06-02, 2017-06-22]
- Azithromycin (03400010) in [2017-07-07, 2017-07-21, 2017-11-17, 2018-03-02, 2018-04-17, 2019-06-18, 2019-09-11, 2019-09-18]
- Metronidazole (16000035) in [2017-07-13]
- Levofloxacin (05000034) in [2017-08-10, 2018-05-22]
- Ciprofloxacin (05000020) in [2017-08-16]

Pain Management:
- Tramadol (65100095) in [2017-06-12, 2017-08-12, 2017-09-20, 2017-10-20, 2017-11-22, 2017-12-22, 2018-01-25, 2018-05-22, 2018-06-20, 2018-07-20, 2018-08-17, 2018-09-18, 2018-10-17, 2018-11-16, 2018-12-19]
- Ibuprofen (66100020) in [2017-05-24, 2017-06-02, 2017-06-23, 2019-07-22]
- Meloxicam (66100052) in [2017-07-07, 2019-07-30, 2019-10-26]
- Diclofenac (90210030) in [2018-03-01, 2018-07-19]
- Tizanidine (75100090) in [2019-07-22]

Cardiovascular:
- Atenolol (33200020) in [2017-06-21]
- Nifedipine (34000020) in [2017-08-07]
- Clopidogrel (85158020) in [2017-08-14, 2017-11-13, 2017-11-17, 2018-02-09, 2018-05-22, 2018-08-17, 2018-11-26, 2018-12-19, 2019-01-24, 2019-05-22, 2019-07-30]
- Simvastatin (39400075) in [2017-09-11, 2017-12-12, 2018-06-17, 2018-12-20, 2019-03-19, 2019-10-18]
- Metoprolol (33200030) in [2017-10-09, 2017-12-18, 2018-03-12, 2018-06-08, 2018-09-18, 2018-12-19, 2019-01-07, 2019-06-18, 2019-09-27, 2019-10-18, 2019-12-26]
- Losartan (36150040) in [2017-10-09, 2017-12-21, 2018-07-27, 2018-11-26]
- Amlodipine (34000003) in [2018-07-27, 2019-05-17, 2019-08-15, 2019-11-10]
- Atorvastatin (39400010) in [2018-07-17, 2018-10-13, 2019-01-23, 2019-04-21, 2019-07-16, 2019-10-11]
- Olmesartan (36150055) in [2019-03-19, 2019-06-13, 2019-10-19]

Hypertension:
- Hydralazine (36400010) in [2017-07-13, 2017-08-16, 2017-09-11, 2017-10-05, 2017-10-30, 2017-11-20, 2017-12-18, 2018-01-16, 2018-03-19, 2019-06-12, 2019-10-18]
- Clonidine (36201010) in [2017-09-30, 2017-12-21, 2018-01-22, 2018-03-04, 2018-04-17, 2018-06-23, 2018-07-17, 2018-09-18, 2018-12-09, 2019-02-11, 2019-03-19, 2019-06-12, 2019-07-16, 2019-10-11, 2019-12-09]
- Hydrochlorothiazide (37600040) in [2018-07-27, 2018-11-26]

Respiratory:
- Fluticasone (42200032) in [2019-01-07, 2019-02-26, 2019-04-18, 2019-06-12, 2019-07-30, 2019-09-28, 2019-11-26]

Psychiatric:
- Trazodone (58120080) in [2018-02-28, 2018-03-27, 2018-04-22, 2018-05-20, 2018-06-20, 2018-09-15, 2018-12-20, 2019-03-19]
- Varenicline (62100080) in [2018-07-17, 2019-03-19]
- Zolpidem (60204080) in [2018-08-07]

Gastrointestinal:
- Ondansetron (50250065) in [2018-05-11]
- Famotidine (49200030) in [2018-01-09]
- Meclizine (50200050) in [2019-02-18]

Vaccines:
- Pneumococcal Vaccine (17200065) in [2018-06-19]

Other:
- Chlorhexidine (88150020) in [2017-05-24, 2017-07-17]
- Sodium Fluoride (88402020) in [2017-05-24, 2017-06-02]
- Prednisone (22100045) in [2018-05-22]
- Penicillin Combination - Two Ingredient (01990002) in [2017-07-17, 2019-01-07]
- Codeine Combination - Two Ingredient (65991002) in [2017-05-24, 2017-06-02, 2017-06-22, 2017-07-17, 2018-02-27]
- Hydrocodone Combination - Two Ingredient (65991702) in [2019-01-18, 2019-02-18, 2019-03-19, 2019-04-19, 2019-05-19, 2019-06-19]
- Adrenergic Combination - Two Ingredient (44209902) in [2019-03-19]
- Adrenergic Combination - Three Ingredient (44209903) in [2019-03-19]
- Angiotensin II Receptor Ant-Ca Channel Blocker-Thiazides (36994503) in [2018-01-25, 2018-02-26, 2018-03-26, 2018-04-24, 2018-05-22, 2018-06-20, 2018-09-26, 2018-12-28]
- Angiotensin II Receptor Antagonists & Thiazides - Two Ingred (36994002) in [2019-02-20, 2019-05-17, 2019-08-15, 2019-11-10]

## Lab Summary

Lab Summary:

Renal Function:
- GFR/BSA pred.black SerPlBld MDRD-ArVRat (48643-1) : [2017-05-26:37.00 L, 2017-07-07:35.00 L, 2017-08-15:12.00 L, 2017-10-05:50.00 L, 2017-10-09:51.00 L, 2018-03-20:58.00 L, 2018-12-19:41.00 L, 2019-02-18:38.00 L, 2019-04-10:48.00 L, 2019-06-18:51.00 L, 2019-07-16:54.00 L]

Hematology:
- RBC # Bld Auto (789-8) : [2017-05-26:3.60 L, 2017-07-07:3.28 L, 2017-08-15:3.41 L, 2017-10-05:3.36 L, 2017-10-09:3.56 L, 2018-12-19:3.36 L, 2019-02-18:3.38 L, 2019-04-10:3.39 L, 2019-06-18:3.22 L, 2019-07-16:3.14 L]
- Hgb Bld-mCnc (718-7) : [2017-05-26:10.60 L, 2017-07-07:9.60 L, 2017-08-15:10.00 L, 2017-10-05:9.50 L, 2017-10-09:10.30 L, 2018-03-20:10.90 L, 2019-02-18:10.20 L, 2019-04-10:10.20 L, 2019-06-18:9.40 L, 2019-07-16:9.70 L]
- Hct VFr Bld Auto (4544-3) : [2017-05-26:32.60 L, 2017-07-07:29.10 L, 2017-08-15:30.80 L, 2017-10-05:30.30 L, 2017-10-09:32.50 L, 2018-03-20:32.20 L, 2019-02-18:30.20 L, 2019-04-10:30.40 L, 2019-06-18:28.00 L, 2019-07-16:28.50 L]
- Platelet # Bld Auto (777-3) : [2017-08-15:470.00 H, 2017-10-05:406.00 H, 2019-06-18:515.00 H]

Liver Function:
- ALT SerPl-cCnc (1742-6) : [2017-10-05:212.00 H, 2017-10-09:158.00 H]
- AST SerPl-cCnc (1920-8) : [2017-10-05:136.00 H, 2017-10-09:105.00 H]

Electrolytes:
- Sodium SerPl-sCnc (2951-2) : [2017-08-15:148.00 H]
- Potassium SerPl-sCnc (2823-3) : [2017-05-26:5.60 H]

Endocrinology:
- TSH SerPl DL<=0.005 mIU/L-aCnc (11580-8) : [2017-05-26:0.39 L]

Metabolic:
- Glucose SerPl-mCnc (2345-7) : [2017-05-26:102.00 H, 2017-10-05:100.00 H, 2018-03-20:101.00 H]
- HbA1c MFr Bld (4548-4) : [2017-05-26:5.70 H, 2017-07-07:6.20 H]

Vitamin Levels:
- 25(OH)D3+25(OH)D2 SerPl-mCnc (62292-8) : [2017-05-26:11.30 L]

Other:
- Creat SerPl-mCnc (2160-0) : [2017-05-26:1.59 H, 2017-07-07:1.67 H, 2017-08-15:4.02 H, 2017-10-05:1.26 H, 2017-10-09:1.22 H, 2018-03-20:1.11 H, 2018-12-19:1.48 H, 2019-02-18:1.55 H, 2019-04-10:1.30 H, 2019-06-18:1.20 H, 2019-07-16:1.14 H]
- ALP SerPl-cCnc (6768-6) : [2017-10-05:603.00 H]

## Past Medical Conditions

# Comprehensive Past Medical Condition Analysis

## List of Top 10 Most Serious Past Medical Conditions

1. Chronic Kidney Disease Stage 3 Moderate
2. Hypertension with Chronic Kidney Disease
3. Unspecified Atrial Fibrillation
4. Acute Kidney Failure
5. Cerebral Atherosclerosis
6. Chronic Obstructive Pulmonary Disease
7. Anemia
8. Nicotine Dependence
9. Hyperlipidemia
10. Type 2 Diabetes Mellitus Without Complications

## Detailed Analysis for Each Condition

### 1. Chronic Kidney Disease Stage 3 Moderate

- **Diagnostic Evidence:**
  - Code: N183, Date: 2017-07-21, Context: CKD Stage 3 Moderate
  - Code: N183, Date: 2017-08-07, Context: CKD Stage 3 Moderate
  - Code: N183, Date: 2017-09-30, Context: CKD Stage 3 Moderate
  - Code: N183, Date: 2018-12-03, Context: CKD Stage 3 Moderate

- **Lab Test Results:**
  - GFR/BSA pred.black SerPlBld MDRD-ArVRat, Date: 2017-05-26, Value: 37.00, Abnormal Code: L
  - GFR/BSA pred.black SerPlBld MDRD-ArVRat, Date: 2017-07-07, Value: 35.00, Abnormal Code: L
  - GFR/BSA pred.black SerPlBld MDRD-ArVRat, Date: 2017-08-15, Value: 12.00, Abnormal Code: L
  - GFR/BSA pred.black SerPlBld MDRD-ArVRat, Date: 2017-10-05, Value: 50.00, Abnormal Code: L

- **Medication History:**
  - Clopidogrel, Date: 2018-02-09, Context: Antiplatelet therapy

- **Explanation:**
  - The consistent diagnosis of CKD Stage 3 Moderate, along with low GFR values, supports the presence of chronic kidney disease. The use of Clopidogrel indicates management of potential cardiovascular risks associated with CKD.

### 2. Hypertension with Chronic Kidney Disease

- **Diagnostic Evidence:**
  - Code: I129, Date: 2017-07-21, Context: HTN CKD W/STAGE 1-4 CKD/UNS CKD
  - Code: I129, Date: 2018-12-19, Context: HTN CKD W/STAGE 1-4 CKD/UNS CKD

- **Procedural Evidence:**
  - Electrocardiogram Complete, Date: 2017-05-26, Context: Monitoring heart function

- **Medication History:**
  - Losartan, Date: 2017-10-09, Context: Antihypertensive therapy
  - Metoprolol, Date: 2018-12-19, Context: Antihypertensive therapy

- **Explanation:**
  - The diagnosis of hypertension with CKD is supported by the consistent diagnostic codes and the use of antihypertensive medications like Losartan and Metoprolol. The electrocardiogram procedure indicates monitoring for potential cardiac complications.

### 3. Unspecified Atrial Fibrillation

- **Diagnostic Evidence:**
  - Code: I4891, Date: 2017-08-13, Context: Unspecified Atrial Fibrillation

- **Procedural Evidence:**
  - Electrocardiogram Tracing, Date: 2017-08-13, Context: Monitoring heart rhythm

- **Medication History:**
  - Clopidogrel, Date: 2018-02-09, Context: Antiplatelet therapy

- **Explanation:**
  - The diagnosis of atrial fibrillation is supported by the diagnostic code and the use of Clopidogrel for stroke prevention. The electrocardiogram tracing indicates monitoring of heart rhythm abnormalities.

### 4. Acute Kidney Failure

- **Diagnostic Evidence:**
  - Code: N179, Date: 2017-08-13, Context: Acute Kidney Failure Unspecified

- **Lab Test Results:**
  - Creat SerPl-mCnc, Date: 2017-08-15, Value: 4.02, Abnormal Code: H

- **Explanation:**
  - The diagnosis of acute kidney failure is supported by the elevated creatinine level, indicating impaired kidney function.

### 5. Cerebral Atherosclerosis

- **Diagnostic Evidence:**
  - Code: I672, Date: 2019-08-26, Context: Cerebral Atherosclerosis

- **Procedural Evidence:**
  - Cardiovascular Stress Test, Date: 2019-09-10, Context: Assessing cardiovascular function

- **Medication History:**
  - Atorvastatin, Date: 2019-01-23, Context: Lipid-lowering therapy

- **Explanation:**
  - The diagnosis of cerebral atherosclerosis is supported by the diagnostic code and the use of Atorvastatin to manage cholesterol levels. The cardiovascular stress test indicates monitoring for potential complications.

### 6. Chronic Obstructive Pulmonary Disease

- **Diagnostic Evidence:**
  - Code: J449, Date: 2019-03-19, Context: COPD Unspecified

- **Medication History:**
  - Fluticasone, Date: 2019-01-07, Context: Inhaled corticosteroid therapy

- **Explanation:**
  - The diagnosis of COPD is supported by the diagnostic code and the use of Fluticasone for managing respiratory symptoms.

### 7. Anemia

- **Diagnostic Evidence:**
  - Code: D649, Date: 2017-09-30, Context: Anemia Unspecified

- **Lab Test Results:**
  - Hgb Bld-mCnc, Date: 2017-10-05, Value: 9.50, Abnormal Code: L

- **Explanation:**
  - The diagnosis of anemia is supported by the low hemoglobin level, indicating reduced red blood cell count.

### 8. Nicotine Dependence

- **Diagnostic Evidence:**
  - Code: F17290, Date: 2017-07-07, Context: Nicotine Dependence Oth Tob Prod Uncomp

- **Procedural Evidence:**
  - Smoking & 2nd Hand Assessed, Date: 2017-08-07, Context: Assessment of smoking status

- **Explanation:**
  - The diagnosis of nicotine dependence is supported by the diagnostic code and the procedural assessment of smoking status.

### 9. Hyperlipidemia

- **Diagnostic Evidence:**
  - Code: E785, Date: 2018-09-18, Context: Hyperlipidemia Unspecified

- **Medication History:**
  - Simvastatin, Date: 2017-09-11, Context: Lipid-lowering therapy

- **Explanation:**
  - The diagnosis of hyperlipidemia is supported by the diagnostic code and the use of Simvastatin to manage cholesterol levels.

### 10. Type 2 Diabetes Mellitus Without Complications

- **Diagnostic Evidence:**
  - Code: E119, Date: 2017-05-26, Context: Type 2 DM Without Complications

- **Lab Test Results:**
  - HbA1c MFr Bld, Date: 2017-05-26, Value: 5.70, Abnormal Code: H

- **Explanation:**
  - The diagnosis of type 2 diabetes is supported by the elevated HbA1c level, indicating poor blood sugar control.

This comprehensive analysis provides a detailed overview of the patient's most serious past medical conditions, supported by diagnostic, procedural, lab, and medication evidence.

## Potential Future Conditions

# Comprehensive Future Medical Condition Analysis

## Prioritized List of Potential Future Medical Conditions

1. Progression of Chronic Kidney Disease
2. Cardiovascular Complications (e.g., Heart Failure, Stroke)
3. Chronic Obstructive Pulmonary Disease Exacerbation
4. Worsening Anemia
5. Diabetes-Related Complications
6. Osteoarthritis Progression
7. Potential for Malignancy
8. Sleep Disorders
9. Gastrointestinal Disorders
10. Vision Impairment

## Detailed Evidence for Each Condition

### 1. Progression of Chronic Kidney Disease

- **Diagnostic Evidence:**
  - Code: N183, Date: Multiple instances, Context: CKD Stage 3 Moderate
  - Code: I129, Date: Multiple instances, Context: Hypertension with CKD

- **Lab Test Evidence:**
  - GFR/BSA pred.black SerPlBld MDRD-ArVRat, consistently low values (e.g., 12.00 on 2017-08-15)
  - Creat SerPl-mCnc, elevated levels (e.g., 4.02 on 2017-08-15)

- **Medication Evidence:**
  - Losartan, Metoprolol, Clopidogrel: Indicating management of hypertension and cardiovascular risks

- **Estimated Timeframe:** 
  - Within 1-2 years, given current trends

- **Risk Factors:**
  - **Primary:** Hypertension, existing CKD
  - **Secondary:** Age, medication side effects

- **Preventive Measures:**
  - Regular monitoring of kidney function
  - Blood pressure management
  - Dietary modifications

- **Explanation:**
  - The consistent diagnosis of CKD Stage 3 and low GFR values suggest a risk of progression to more severe stages.

### 2. Cardiovascular Complications

- **Diagnostic Evidence:**
  - Code: I672, Date: 2019-08-26, Context: Cerebral Atherosclerosis
  - Code: I129, Date: Multiple instances, Context: Hypertension with CKD

- **Procedural Evidence:**
  - Cardiovascular Stress Test, Date: 2019-09-10

- **Medication Evidence:**
  - Atorvastatin, Clopidogrel: Indicating management of cholesterol and prevention of thrombotic events

- **Estimated Timeframe:** 
  - Within 1-3 years

- **Risk Factors:**
  - **Primary:** Hypertension, hyperlipidemia
  - **Secondary:** Smoking history, age

- **Preventive Measures:**
  - Regular cardiovascular assessments
  - Lifestyle modifications (e.g., smoking cessation, exercise)

- **Explanation:**
  - The presence of cerebral atherosclerosis and hypertension increases the risk of cardiovascular events.

### 3. Chronic Obstructive Pulmonary Disease Exacerbation

- **Diagnostic Evidence:**
  - Code: J449, Date: 2019-03-19, Context: COPD Unspecified

- **Medication Evidence:**
  - Fluticasone: Indicating management of respiratory symptoms

- **Estimated Timeframe:** 
  - Within 1 year, especially during flu season

- **Risk Factors:**
  - **Primary:** Smoking history, existing COPD
  - **Secondary:** Environmental pollutants

- **Preventive Measures:**
  - Vaccinations (e.g., flu, pneumococcal)
  - Avoidance of respiratory irritants

- **Explanation:**
  - The diagnosis of COPD and smoking history suggest a risk of exacerbations.

### 4. Worsening Anemia

- **Diagnostic Evidence:**
  - Code: D649, Date: Multiple instances, Context: Anemia Unspecified

- **Lab Test Evidence:**
  - Hgb Bld-mCnc, consistently low values (e.g., 9.50 on 2017-10-05)

- **Estimated Timeframe:** 
  - Within 6 months to 1 year

- **Risk Factors:**
  - **Primary:** Chronic disease, potential nutritional deficiencies
  - **Secondary:** Age, medication side effects

- **Preventive Measures:**
  - Regular blood tests
  - Nutritional supplementation

- **Explanation:**
  - The persistent low hemoglobin levels indicate a risk of worsening anemia.

### 5. Diabetes-Related Complications

- **Diagnostic Evidence:**
  - Code: E119, Date: 2017-05-26, Context: Type 2 DM Without Complications

- **Lab Test Evidence:**
  - HbA1c MFr Bld, elevated levels (e.g., 5.70 on 2017-05-26)

- **Estimated Timeframe:** 
  - Within 1-2 years

- **Risk Factors:**
  - **Primary:** Poor glycemic control
  - **Secondary:** Lifestyle factors

- **Preventive Measures:**
  - Regular monitoring of blood glucose
  - Lifestyle modifications (e.g., diet, exercise)

- **Explanation:**
  - The elevated HbA1c level suggests a risk of developing complications related to diabetes.

### 6. Osteoarthritis Progression

- **Diagnostic Evidence:**
  - Code: M1990, Date: Multiple instances, Context: Unspecified Osteoarthritis

- **Medication Evidence:**
  - Meloxicam, Ibuprofen: Indicating management of pain and inflammation

- **Estimated Timeframe:** 
  - Within 1-3 years

- **Risk Factors:**
  - **Primary:** Age, existing joint issues
  - **Secondary:** Obesity, physical activity level

- **Preventive Measures:**
  - Weight management
  - Physical therapy

- **Explanation:**
  - The diagnosis of osteoarthritis and use of pain medications suggest a risk of progression.

### 7. Potential for Malignancy

- **Diagnostic Evidence:**
  - Code: Z1211, Date: Multiple instances, Context: Screening for Malignant Neoplasm

- **Procedural Evidence:**
  - Colonoscopy, Date: 2018-01-19

- **Estimated Timeframe:** 
  - Within 5 years

- **Risk Factors:**
  - **Primary:** Age, family history
  - **Secondary:** Lifestyle factors

- **Preventive Measures:**
  - Regular cancer screenings
  - Lifestyle modifications

- **Explanation:**
  - The regular screening for malignancies indicates a proactive approach to potential cancer risks.

### 8. Sleep Disorders

- **Diagnostic Evidence:**
  - Code: G4700, Date: Multiple instances, Context: Insomnia Unspecified

- **Medication Evidence:**
  - Trazodone, Zolpidem: Indicating management of sleep issues

- **Estimated Timeframe:** 
  - Ongoing

- **Risk Factors:**
  - **Primary:** Stress, existing insomnia
  - **Secondary:** Medication side effects

- **Preventive Measures:**
  - Sleep hygiene education
  - Cognitive behavioral therapy

- **Explanation:**
  - The diagnosis of insomnia and use of sleep medications suggest ongoing sleep disturbances.

### 9. Gastrointestinal Disorders

- **Diagnostic Evidence:**
  - Code: K921, Date: Multiple instances, Context: Melena

- **Procedural Evidence:**
  - EGD Biopsy, Date: 2018-01-19

- **Estimated Timeframe:** 
  - Within 1 year

- **Risk Factors:**
  - **Primary:** Existing GI issues
  - **Secondary:** Medication side effects

- **Preventive Measures:**
  - Regular GI assessments
  - Dietary modifications

- **Explanation:**
  - The presence of melena and GI procedures suggest a risk of gastrointestinal complications.

### 10. Vision Impairment

- **Diagnostic Evidence:**
  - Code: H2512, Date: 2018-09-06, Context: Age-Related Nuclear Cataract

- **Procedural Evidence:**
  - Eye Exam, Date: 2018-09-06

- **Estimated Timeframe:** 
  - Within 2-3 years

- **Risk Factors:**
  - **Primary:** Age, existing cataracts
  - **Secondary:** Diabetes

- **Preventive Measures:**
  - Regular eye exams
  - Management of underlying conditions

- **Explanation:**
  - The diagnosis of cataracts and regular eye exams suggest a risk of vision impairment.

This comprehensive analysis provides a detailed overview of potential future medical conditions, supported by diagnostic, procedural, lab, and medication evidence.

## Common Q&A

# Important Questions to Discuss with Your Doctor

*Disclaimer: The following content is generated with the assistance of a language model and is intended to help guide your discussion with your healthcare provider. It is not a substitute for professional medical advice.*

## Question 1: **What is the current status of my Chronic Kidney Disease (CKD) and how can I manage it effectively?**

**Answer:** Chronic Kidney Disease (CKD) Stage 3 indicates moderate kidney damage, with a GFR (Glomerular Filtration Rate) between 30 and 59. Your lab results show fluctuating GFR values, with a low of 12.00 and a high of 58.00, indicating varying kidney function over time. Management typically involves controlling blood pressure, managing diabetes, and reducing protein intake. Medications like Losartan and Metoprolol are often used to manage hypertension, which is crucial in slowing CKD progression. Regular monitoring of kidney function and lifestyle modifications, such as a low-sodium diet and avoiding NSAIDs, are also recommended.

**Importance:** Understanding the current status of your CKD and its management is vital to prevent further kidney damage and complications. Discussing this with your doctor can help tailor a treatment plan that addresses your specific needs and lifestyle.

## Question 2: **What are my treatment options for managing hypertension and preventing cardiovascular complications?**

**Answer:** Hypertension, especially when combined with CKD, increases the risk of cardiovascular complications. Your medication regimen includes antihypertensives like Losartan, Metoprolol, and Amlodipine, which help control blood pressure. Additionally, statins like Atorvastatin are used to manage cholesterol levels, reducing the risk of atherosclerosis and heart disease. Lifestyle changes, such as a heart-healthy diet, regular exercise, and smoking cessation, are also crucial components of managing hypertension and preventing cardiovascular events.

**Importance:** Effective management of hypertension is critical in reducing the risk of heart attacks, strokes, and further kidney damage. Discussing treatment options with your doctor ensures that your plan is comprehensive and considers all risk factors.

## Question 3: **What lifestyle modifications can I make to improve my overall health and prevent future complications?**

**Answer:** Lifestyle modifications play a significant role in managing chronic conditions and preventing complications. For CKD and hypertension, a low-sodium, balanced diet is recommended. Regular physical activity can help manage weight, improve cardiovascular health, and enhance overall well-being. Smoking cessation is crucial, given your history of nicotine dependence, as it significantly reduces the risk of cardiovascular and respiratory complications. Additionally, managing stress and ensuring adequate sleep can improve your quality of life and health outcomes.

**Importance:** Lifestyle changes are a powerful tool in managing chronic diseases and improving health outcomes. Discussing these with your doctor can provide you with personalized recommendations and support to implement these changes effectively.

